In the present study, esophageal cancer (FLO-1) cells treated with different anticancer drugs such as platinum-based DNA damaging agents (cisplatin), the DNA topoisomerase I inhibitors class of drugs (irinotecan) [45], and 5-FU that interferes with thymidine nucleotide synthesis [46]. This evidence concerns the gene TOP1 and esophageal cancer.